Skip to content

The outcome of treatment using antibiotic articulating cement spacers for prosthetic joint infection: A retrospective study.

The outcome of treatment using antibiotic articulating cement spacers for prosthetic joint infection: A retrospective study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORC-17012277
Enrollment
Unknown
Registered
2017-08-07
Start date
2017-09-30
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periprosthetic joint infection

Interventions

Sponsors

The Sixth People's Hospital of Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. All the patients with periprosthetic hip infection from 2011 through April 2016 were reviewed at Shanghai 6th Peoples Hospital. PJI is defined as: Two positive periprosthetic cultures with phenotypicallyidentical organisms, or A sinus tract communicating with the joint, or Having three of the following minor criteria:- Elevated serum C-reactive protein (CRP) AND erythrocyte sedimentation rate (ESR) - Elevated synovial fluid white blood cell (WBC) count OR ttchange on leukocyte esterase test strip - Elevated synovial fluid polymorphonuclear neutrophil percentage (PMN%) - Positive histological analysis of periprosthetic tissue - A single positive culture. 2. Patients older than 18 years old, less than 90 years old; 3. Periprosthetic joint infection after total hip or knee infection.

Exclusion criteria

Exclusion criteria: Patients with superficial/deep surgical site infection or patients undergoing one-stage revision or septic arthritis patients were excluded.

Design outcomes

Primary

MeasureTime frame
infection control status;

Secondary

MeasureTime frame
intro-operative pathology;preoperative microbiology;intra-operative culture;Complications (infection excluded);

Countries

China

Contacts

Public ContactZhang Xianlong

The Sixth People's Hospital of Shanghai

dr_zhangxianlong@163.com+86 13817875071

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026